Framatome And TUM Begin Commercial Development :: The Independent Global Nuclear News Agency: French nuclear company Framatome and the Technical University of Munich have begun the commercial development of uranium-molybdenum fuel (UMo) for nuclear research reactors.
Framatome and TUM will design and install a fuel manufacturing production line, and develop, produce and irradiate new fuel prototypes.
The project will take place at the Cerca Research and Innovation Lab (CRIL), Framatome’s new research and development laboratory for the fabrication of nuclear fuels for medical, research and sterilisation applications.
No comments:
Post a Comment